Login
Sign Up
Login
Sign Up
Features
Pricing
Reg.News
Contact
Login
Sign Up
Search
Providers
Companies
⨯
LIVE
Event in Progress:
Join Here
×
Search
Providers
Companies
⨯
Features
Pricing
Event Hub
Reg.News
Short Interest
Contact
All the news articles and press releases in one place.
UK Reg. News
German Reg. News
Search
Key Announcements
Results / Trading Updates
Get free RNS email alerts for@Model.CurrentFilterValue
Currently filtered for Abzena
Clear Filter
Sector
Automobile Industry
Banks
Basic Materials
Building & Construction
Chemicals
Consumer Discretionary Goods
Consumer Discretionary Services
Consumer Staple Goods
Consumer Staple Services
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Finance
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Trusts, ETFs & Funds
Utilities
Market Cap
Below £20m
£20m - £100m
£100m - £300m
£300m - £1bn
£1bn - £10bn
Over £10bn
Filters »
All
UK100
UK250
UK SmallCap
UK Other
Show:
10
25
50
100
«
1
»
Date / Time
Source
Ticker
Company
Sector
Market Cap
Announcement
11Oct18 07:44
RNS
ABZA:LON
Abzena
Health
£54.0m
Scheme of Arrangement becomes Effective
11Oct18 07:30
RNS
ABZA:LON
Abzena
Health
£54.0m
Suspension - Abzena Plc
10Oct18 14:42
RNS
ABZA:LON
Abzena
Health
£54.0m
Court sanction of the scheme of arrangement
10Oct18 14:40
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of options
04Oct18 17:30
RNS
ABZA:LON
Abzena
Health
£54.0m
Abzena
02Oct18 13:51
RNS
ABZA:LON
Abzena
Health
£54.0m
Results of Court Meeting and General Meeting
17Sep18 12:55
RNS
ABZA:LON
Abzena
Health
£54.0m
Result of Annual General Meeting
10Sep18 13:35
RNS
ABZA:LON
Abzena
Health
£54.0m
Posting of Scheme Document
30Aug18 18:28
RNS
ABZA:LON
Abzena
Health
£54.0m
Change of Adviser
23Aug18 16:48
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of AGM
16Aug18 07:19
RNS
ABZA:LON
Abzena
Health
£54.0m
Update on partial monetisation
16Aug18 07:16
RNS
ABZA:LON
Abzena
Health
£54.0m
Recommended Cash Offer for Abzena plc
06Jul18 15:55
RNS
ABZA:LON
Abzena
Health
£54.0m
Blocklisting update
02Jul18 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Abzena and Telix sign manufacturing agreement
19Jun18 12:28
RNS
ABZA:LON
Abzena
Health
£54.0m
Annual Report and Accounts
14Jun18 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Funding update
04Jun18 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Final Results
29May18 09:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of full year results
16Apr18 07:25
RNS
ABZA:LON
Abzena
Health
£54.0m
Pre-Close Period Trading Update FY2018
09Apr18 08:25
RNS
ABZA:LON
Abzena
Health
£54.0m
Termination of licence agreement
29Mar18 17:34
RNS
ABZA:LON
Abzena
Health
£54.0m
Issue of Ordinary Shares
05Mar18 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
PacificGMP Stanford Settlement
12Dec17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Half year results: Growth strategy progressing
11Dec17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Abzena secures ADC manufacturing services contract
21Nov17 09:51
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of half year results
08Nov17 14:28
RNS
ABZA:LON
Abzena
Health
£54.0m
TR-1: Notification of major holdings
24Oct17 16:15
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of options
19Sep17 14:25
RNS
ABZA:LON
Abzena
Health
£54.0m
TR-1: Notification of Major Holdings
19Sep17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Appointment of Non-Executive Director
18Sep17 17:41
RNS
ABZA:LON
Abzena
Health
£54.0m
TR-1: Notification of Major Holdings
14Sep17 12:46
RNS
ABZA:LON
Abzena
Health
£54.0m
Result of AGM
14Sep17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Trading Update
29Aug17 14:59
RNS
ABZA:LON
Abzena
Health
£54.0m
TR-1: Notification of major holdings
29Aug17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Notification of claim
21Aug17 13:44
RNS
ABZA:LON
Abzena
Health
£54.0m
Holding(s) in Company
28Jul17 12:27
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of AGM
18Jul17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Abzena and Telix sign licence agreement
11Jul17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Abzena and OBI Pharma sign licence agreement
04Jul17 11:24
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of Options
30Jun17 17:19
RNS
ABZA:LON
Abzena
Health
£54.0m
TR-1: Notification of Major Interest in Shares
19Jun17 17:18
RNS
ABZA:LON
Abzena
Health
£54.0m
Annual Report and Accounts
13Jun17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Final Results
26May17 17:24
RNS
ABZA:LON
Abzena
Health
£54.0m
TR-1: Notification of Major Interest in Shares
16May17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of Full Year Results
03May17 12:58
EQS
ABZA:LON
Abzena
Health
£54.0m
Edison issues outlook on Abzena (ABZA)
27Apr17 11:09
RNS
ABZA:LON
Abzena
Health
£54.0m
TR-1: Notification of Major Interest in Shares
21Apr17 11:21
RNS
IVO:LON, ABZA:LON
Abzena, Touchstone Innovations
Various
Various
Innovations invests £2.9m in Abzena placing
21Apr17 11:20
RNS
ABZA:LON
Abzena
Health
£54.0m
Result of General Meeting
11Apr17 15:06
RNS
ABZA:LON
Abzena
Health
£54.0m
Director/PDMR Shareholding
07Apr17 13:36
RNS
ABZA:LON
Abzena
Health
£54.0m
Grant of options
05Apr17 15:45
RNS
ABZA:LON
Abzena
Health
£54.0m
Result of bookbuild
05Apr17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Proposed Placing of £25m
21Feb17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Trading and business update
08Feb17 08:43
EQS
ABZA:LON
Abzena
Health
£54.0m
Edison issues outlook on Abzena
06Feb17 10:55
RNS
ABZA:LON
Abzena
Health
£54.0m
Total Voting Rights
24Jan17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Issue of Equity
20Jan17 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
ThioBridge license agreement
09Jan17 09:37
RNS
ABZA:LON
Abzena
Health
£54.0m
Blocklisting update
22Dec16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Licence agreement
30Nov16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Half year results
23Nov16 08:09
RNS
ABZA:LON
Abzena
Health
£54.0m
'Abzena inside' product study data to be presented
15Nov16 12:42
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of half year results
02Nov16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Licensed product candidate update
21Oct16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Licensed product candidate update
22Sep16 09:30
RNS
ABZA:LON
Abzena
Health
£54.0m
Licensed product candidate update
19Sep16 14:28
RNS
ABZA:LON
Abzena
Health
£54.0m
Change of Nominated Adviser and Broker
13Sep16 15:41
RNS
ABZA:LON
Abzena
Health
£54.0m
Result of AGM
13Sep16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Directorate Change
13Sep16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
AGM Business Update
16Aug16 12:20
RNS
ABZA:LON
Abzena
Health
£54.0m
Director/PDMR Shareholding and Exercise of Options
09Aug16 14:30
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of AGM
27Jun16 16:46
RNS
ABZA:LON
Abzena
Health
£54.0m
Director Dealings
24Jun16 09:45
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of warrants
15Jun16 16:09
RNS
ABZA:LON
Abzena
Health
£54.0m
Annual Report and Accounts
14Jun16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Full year results
26May16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Notice of Results
05Apr16 09:20
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of Employee Share Options
01Apr16 09:48
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of Share Options and Director Dealings
16Mar16 09:45
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of Employee Share Options
09Mar16 12:47
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of Employee Share Options
09Mar16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Business update
08Feb16 15:14
RNS
ABZA:LON
Abzena
Health
£54.0m
Exercise of employee share options
04Feb16 14:33
RNS
ABZA:LON
Abzena
Health
£54.0m
Holding(s) in Company
25Jan16 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Significant licence deal for ThioBridgeT
11Jan16 14:14
RNS
ABZA:LON
Abzena
Health
£54.0m
Holding(s) in Company
05Jan16 15:18
RNS
ABZA:LON
Abzena
Health
£54.0m
Blocklisting Interim Review
18Dec15 14:21
RNS
ABZA:LON
Abzena
Health
£54.0m
Holding(s) in Company
15Dec15 11:42
RNS
PGOO:LON, ABZA:LON
Abzena, ProVen Growth & Income VCT Plc
Various
Various
Holding(s) in Company
11Dec15 16:12
RNS
ABZA:LON
Abzena
Health
£54.0m
Holding(s) in Company
11Dec15 15:13
RNS
ABZA:LON
Abzena
Health
£54.0m
Completion of Acquisition
10Dec15 12:15
RNS
ABZA:LON
Abzena
Health
£54.0m
Result of General Meeting
24Nov15 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Placing to raise £20 million and acquisition
24Nov15 07:00
RNS
ABZA:LON
Abzena
Health
£54.0m
Half year results
21Oct15 09:52
RNS
ABZA:LON
Abzena
Health
£54.0m
Appointment of joint broker
09Oct15 12:34
RNS
ABZA:LON
Abzena
Health
£54.0m
Adheron Therapeutics acquired by Roche
«
1
»
Date / Time
Source
Company
% Chg
11Oct18 07:44
RNS
Abzena
-0.90%
Scheme of Arrangement becomes Effective
11Oct18 07:30
RNS
Abzena
-0.90%
Suspension - Abzena Plc
10Oct18 14:42
RNS
Abzena
-0.90%
Court sanction of the scheme of arrangement
10Oct18 14:40
RNS
Abzena
-0.90%
Exercise of options
04Oct18 17:30
RNS
Abzena
-0.90%
Abzena
02Oct18 13:51
RNS
Abzena
-0.90%
Results of Court Meeting and General Meeting
17Sep18 12:55
RNS
Abzena
-0.90%
Result of Annual General Meeting
10Sep18 13:35
RNS
Abzena
-0.90%
Posting of Scheme Document
30Aug18 18:28
RNS
Abzena
-0.90%
Change of Adviser
23Aug18 16:48
RNS
Abzena
-0.90%
Notice of AGM
16Aug18 07:19
RNS
Abzena
-0.90%
Update on partial monetisation
16Aug18 07:16
RNS
Abzena
-0.90%
Recommended Cash Offer for Abzena plc
06Jul18 15:55
RNS
Abzena
-0.90%
Blocklisting update
02Jul18 07:00
RNS
Abzena
-0.90%
Abzena and Telix sign manufacturing agreement
19Jun18 12:28
RNS
Abzena
-0.90%
Annual Report and Accounts
14Jun18 07:00
RNS
Abzena
-0.90%
Funding update
04Jun18 07:00
RNS
Abzena
-0.90%
Final Results
29May18 09:00
RNS
Abzena
-0.90%
Notice of full year results
16Apr18 07:25
RNS
Abzena
-0.90%
Pre-Close Period Trading Update FY2018
09Apr18 08:25
RNS
Abzena
-0.90%
Termination of licence agreement
29Mar18 17:34
RNS
Abzena
-0.90%
Issue of Ordinary Shares
05Mar18 07:00
RNS
Abzena
-0.90%
PacificGMP Stanford Settlement
12Dec17 07:00
RNS
Abzena
-0.90%
Half year results: Growth strategy progressing
11Dec17 07:00
RNS
Abzena
-0.90%
Abzena secures ADC manufacturing services contract
21Nov17 09:51
RNS
Abzena
-0.90%
Notice of half year results
08Nov17 14:28
RNS
Abzena
-0.90%
TR-1: Notification of major holdings
24Oct17 16:15
RNS
Abzena
-0.90%
Exercise of options
19Sep17 14:25
RNS
Abzena
-0.90%
TR-1: Notification of Major Holdings
19Sep17 07:00
RNS
Abzena
-0.90%
Appointment of Non-Executive Director
18Sep17 17:41
RNS
Abzena
-0.90%
TR-1: Notification of Major Holdings
14Sep17 12:46
RNS
Abzena
-0.90%
Result of AGM
14Sep17 07:00
RNS
Abzena
-0.90%
Trading Update
29Aug17 14:59
RNS
Abzena
-0.90%
TR-1: Notification of major holdings
29Aug17 07:00
RNS
Abzena
-0.90%
Notification of claim
21Aug17 13:44
RNS
Abzena
-0.90%
Holding(s) in Company
28Jul17 12:27
RNS
Abzena
-0.90%
Notice of AGM
18Jul17 07:00
RNS
Abzena
-0.90%
Abzena and Telix sign licence agreement
11Jul17 07:00
RNS
Abzena
-0.90%
Abzena and OBI Pharma sign licence agreement
04Jul17 11:24
RNS
Abzena
-0.90%
Exercise of Options
30Jun17 17:19
RNS
Abzena
-0.90%
TR-1: Notification of Major Interest in Shares
19Jun17 17:18
RNS
Abzena
-0.90%
Annual Report and Accounts
13Jun17 07:00
RNS
Abzena
-0.90%
Final Results
26May17 17:24
RNS
Abzena
-0.90%
TR-1: Notification of Major Interest in Shares
16May17 07:00
RNS
Abzena
-0.90%
Notice of Full Year Results
03May17 12:58
EQS
Abzena
-0.90%
Edison issues outlook on Abzena (ABZA)
27Apr17 11:09
RNS
Abzena
-0.90%
TR-1: Notification of Major Interest in Shares
21Apr17 11:21
RNS
Abzena, Touchstone Innovations
0.00%
Innovations invests £2.9m in Abzena placing
21Apr17 11:20
RNS
Abzena
-0.90%
Result of General Meeting
11Apr17 15:06
RNS
Abzena
-0.90%
Director/PDMR Shareholding
07Apr17 13:36
RNS
Abzena
-0.90%
Grant of options
05Apr17 15:45
RNS
Abzena
-0.90%
Result of bookbuild
05Apr17 07:00
RNS
Abzena
-0.90%
Proposed Placing of £25m
21Feb17 07:00
RNS
Abzena
-0.90%
Trading and business update
08Feb17 08:43
EQS
Abzena
-0.90%
Edison issues outlook on Abzena
06Feb17 10:55
RNS
Abzena
-0.90%
Total Voting Rights
24Jan17 07:00
RNS
Abzena
-0.90%
Issue of Equity
20Jan17 07:00
RNS
Abzena
-0.90%
ThioBridge license agreement
09Jan17 09:37
RNS
Abzena
-0.90%
Blocklisting update
22Dec16 07:00
RNS
Abzena
-0.90%
Licence agreement
30Nov16 07:00
RNS
Abzena
-0.90%
Half year results
23Nov16 08:09
RNS
Abzena
-0.90%
'Abzena inside' product study data to be presented
15Nov16 12:42
RNS
Abzena
-0.90%
Notice of half year results
02Nov16 07:00
RNS
Abzena
-0.90%
Licensed product candidate update
21Oct16 07:00
RNS
Abzena
-0.90%
Licensed product candidate update
22Sep16 09:30
RNS
Abzena
-0.90%
Licensed product candidate update
19Sep16 14:28
RNS
Abzena
-0.90%
Change of Nominated Adviser and Broker
13Sep16 15:41
RNS
Abzena
-0.90%
Result of AGM
13Sep16 07:00
RNS
Abzena
-0.90%
Directorate Change
13Sep16 07:00
RNS
Abzena
-0.90%
AGM Business Update
16Aug16 12:20
RNS
Abzena
-0.90%
Director/PDMR Shareholding and Exercise of Options
09Aug16 14:30
RNS
Abzena
-0.90%
Notice of AGM
27Jun16 16:46
RNS
Abzena
-0.90%
Director Dealings
24Jun16 09:45
RNS
Abzena
-0.90%
Exercise of warrants
15Jun16 16:09
RNS
Abzena
-0.90%
Annual Report and Accounts
14Jun16 07:00
RNS
Abzena
-0.90%
Full year results
26May16 07:00
RNS
Abzena
-0.90%
Notice of Results
05Apr16 09:20
RNS
Abzena
-0.90%
Exercise of Employee Share Options
01Apr16 09:48
RNS
Abzena
-0.90%
Exercise of Share Options and Director Dealings
16Mar16 09:45
RNS
Abzena
-0.90%
Exercise of Employee Share Options
09Mar16 12:47
RNS
Abzena
-0.90%
Exercise of Employee Share Options
09Mar16 07:00
RNS
Abzena
-0.90%
Business update
08Feb16 15:14
RNS
Abzena
-0.90%
Exercise of employee share options
04Feb16 14:33
RNS
Abzena
-0.90%
Holding(s) in Company
25Jan16 07:00
RNS
Abzena
-0.90%
Significant licence deal for ThioBridgeT
11Jan16 14:14
RNS
Abzena
-0.90%
Holding(s) in Company
05Jan16 15:18
RNS
Abzena
-0.90%
Blocklisting Interim Review
18Dec15 14:21
RNS
Abzena
-0.90%
Holding(s) in Company
15Dec15 11:42
RNS
Abzena, ProVen Growth & Income VCT Plc
0.00%
Holding(s) in Company
11Dec15 16:12
RNS
Abzena
-0.90%
Holding(s) in Company
11Dec15 15:13
RNS
Abzena
-0.90%
Completion of Acquisition
10Dec15 12:15
RNS
Abzena
-0.90%
Result of General Meeting
24Nov15 07:00
RNS
Abzena
-0.90%
Placing to raise £20 million and acquisition
24Nov15 07:00
RNS
Abzena
-0.90%
Half year results
21Oct15 09:52
RNS
Abzena
-0.90%
Appointment of joint broker
09Oct15 12:34
RNS
Abzena
-0.90%
Adheron Therapeutics acquired by Roche
«
1
»
Date / Time
Company
% Chg
11Oct18 07:44
Abzena
-0.90%
Scheme of Arrangement becomes Effective
11Oct18 07:30
Abzena
-0.90%
Suspension - Abzena Plc
10Oct18 14:42
Abzena
-0.90%
Court sanction of the scheme of arrangement
10Oct18 14:40
Abzena
-0.90%
Exercise of options
04Oct18 17:30
Abzena
-0.90%
Abzena
02Oct18 13:51
Abzena
-0.90%
Results of Court Meeting and General Meeting
17Sep18 12:55
Abzena
-0.90%
Result of Annual General Meeting
10Sep18 13:35
Abzena
-0.90%
Posting of Scheme Document
30Aug18 18:28
Abzena
-0.90%
Change of Adviser
23Aug18 16:48
Abzena
-0.90%
Notice of AGM
16Aug18 07:19
Abzena
-0.90%
Update on partial monetisation
16Aug18 07:16
Abzena
-0.90%
Recommended Cash Offer for Abzena plc
06Jul18 15:55
Abzena
-0.90%
Blocklisting update
02Jul18 07:00
Abzena
-0.90%
Abzena and Telix sign manufacturing agreement
19Jun18 12:28
Abzena
-0.90%
Annual Report and Accounts
14Jun18 07:00
Abzena
-0.90%
Funding update
04Jun18 07:00
Abzena
-0.90%
Final Results
29May18 09:00
Abzena
-0.90%
Notice of full year results
16Apr18 07:25
Abzena
-0.90%
Pre-Close Period Trading Update FY2018
09Apr18 08:25
Abzena
-0.90%
Termination of licence agreement
29Mar18 17:34
Abzena
-0.90%
Issue of Ordinary Shares
05Mar18 07:00
Abzena
-0.90%
PacificGMP Stanford Settlement
12Dec17 07:00
Abzena
-0.90%
Half year results: Growth strategy progressing
11Dec17 07:00
Abzena
-0.90%
Abzena secures ADC manufacturing services contract
21Nov17 09:51
Abzena
-0.90%
Notice of half year results
08Nov17 14:28
Abzena
-0.90%
TR-1: Notification of major holdings
24Oct17 16:15
Abzena
-0.90%
Exercise of options
19Sep17 14:25
Abzena
-0.90%
TR-1: Notification of Major Holdings
19Sep17 07:00
Abzena
-0.90%
Appointment of Non-Executive Director
18Sep17 17:41
Abzena
-0.90%
TR-1: Notification of Major Holdings
14Sep17 12:46
Abzena
-0.90%
Result of AGM
14Sep17 07:00
Abzena
-0.90%
Trading Update
29Aug17 14:59
Abzena
-0.90%
TR-1: Notification of major holdings
29Aug17 07:00
Abzena
-0.90%
Notification of claim
21Aug17 13:44
Abzena
-0.90%
Holding(s) in Company
28Jul17 12:27
Abzena
-0.90%
Notice of AGM
18Jul17 07:00
Abzena
-0.90%
Abzena and Telix sign licence agreement
11Jul17 07:00
Abzena
-0.90%
Abzena and OBI Pharma sign licence agreement
04Jul17 11:24
Abzena
-0.90%
Exercise of Options
30Jun17 17:19
Abzena
-0.90%
TR-1: Notification of Major Interest in Shares
19Jun17 17:18
Abzena
-0.90%
Annual Report and Accounts
13Jun17 07:00
Abzena
-0.90%
Final Results
26May17 17:24
Abzena
-0.90%
TR-1: Notification of Major Interest in Shares
16May17 07:00
Abzena
-0.90%
Notice of Full Year Results
03May17 12:58
Abzena
-0.90%
Edison issues outlook on Abzena (ABZA)
27Apr17 11:09
Abzena
-0.90%
TR-1: Notification of Major Interest in Shares
21Apr17 11:21
ABZA LSE,IVO LSE
0.00%
Innovations invests £2.9m in Abzena placing
21Apr17 11:20
Abzena
-0.90%
Result of General Meeting
11Apr17 15:06
Abzena
-0.90%
Director/PDMR Shareholding
07Apr17 13:36
Abzena
-0.90%
Grant of options
05Apr17 15:45
Abzena
-0.90%
Result of bookbuild
05Apr17 07:00
Abzena
-0.90%
Proposed Placing of £25m
21Feb17 07:00
Abzena
-0.90%
Trading and business update
08Feb17 08:43
Abzena
-0.90%
Edison issues outlook on Abzena
06Feb17 10:55
Abzena
-0.90%
Total Voting Rights
24Jan17 07:00
Abzena
-0.90%
Issue of Equity
20Jan17 07:00
Abzena
-0.90%
ThioBridge license agreement
09Jan17 09:37
Abzena
-0.90%
Blocklisting update
22Dec16 07:00
Abzena
-0.90%
Licence agreement
30Nov16 07:00
Abzena
-0.90%
Half year results
23Nov16 08:09
Abzena
-0.90%
'Abzena inside' product study data to be presented
15Nov16 12:42
Abzena
-0.90%
Notice of half year results
02Nov16 07:00
Abzena
-0.90%
Licensed product candidate update
21Oct16 07:00
Abzena
-0.90%
Licensed product candidate update
22Sep16 09:30
Abzena
-0.90%
Licensed product candidate update
19Sep16 14:28
Abzena
-0.90%
Change of Nominated Adviser and Broker
13Sep16 15:41
Abzena
-0.90%
Result of AGM
13Sep16 07:00
Abzena
-0.90%
Directorate Change
13Sep16 07:00
Abzena
-0.90%
AGM Business Update
16Aug16 12:20
Abzena
-0.90%
Director/PDMR Shareholding and Exercise of Options
09Aug16 14:30
Abzena
-0.90%
Notice of AGM
27Jun16 16:46
Abzena
-0.90%
Director Dealings
24Jun16 09:45
Abzena
-0.90%
Exercise of warrants
15Jun16 16:09
Abzena
-0.90%
Annual Report and Accounts
14Jun16 07:00
Abzena
-0.90%
Full year results
26May16 07:00
Abzena
-0.90%
Notice of Results
05Apr16 09:20
Abzena
-0.90%
Exercise of Employee Share Options
01Apr16 09:48
Abzena
-0.90%
Exercise of Share Options and Director Dealings
16Mar16 09:45
Abzena
-0.90%
Exercise of Employee Share Options
09Mar16 12:47
Abzena
-0.90%
Exercise of Employee Share Options
09Mar16 07:00
Abzena
-0.90%
Business update
08Feb16 15:14
Abzena
-0.90%
Exercise of employee share options
04Feb16 14:33
Abzena
-0.90%
Holding(s) in Company
25Jan16 07:00
Abzena
-0.90%
Significant licence deal for ThioBridgeT
11Jan16 14:14
Abzena
-0.90%
Holding(s) in Company
05Jan16 15:18
Abzena
-0.90%
Blocklisting Interim Review
18Dec15 14:21
Abzena
-0.90%
Holding(s) in Company
15Dec15 11:42
ABZA LSE,PGOO LSE
0.00%
Holding(s) in Company
11Dec15 16:12
Abzena
-0.90%
Holding(s) in Company
11Dec15 15:13
Abzena
-0.90%
Completion of Acquisition
10Dec15 12:15
Abzena
-0.90%
Result of General Meeting
24Nov15 07:00
Abzena
-0.90%
Placing to raise £20 million and acquisition
24Nov15 07:00
Abzena
-0.90%
Half year results
21Oct15 09:52
Abzena
-0.90%
Appointment of joint broker
09Oct15 12:34
Abzena
-0.90%
Adheron Therapeutics acquired by Roche
«
1
»
Strapline
Strapline
Question 1
Answer 1
Question 2
Answer 2
Question 3
Answer 3
Question 4
Answer 4
Question 5
Answer 5
Question 6
Answer 6
Question 7
Answer 7
Question 8
Answer 8
Top
Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Explore Content
Regions
UK
Rest of EMEA
N America
APAC
LatAm
Exchanges
Aquis Apex
Australian Securities Exchange
Canadian Securities Exchange
Euronext Paris
London Stock Exchange (domestic)
SIX Swiss Exchange
Sectors
Automobile Industry
Banks
Building & Construction
Chemicals
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Utilities
Small / Large Cap
UK100
UK250
UK Smallcap
UK Other Main Markets
Other
Private/EIS
EIS Single Company
EIS/SEIS Funds
IHT Products
SEIS Single Company
VCT Funds
Providers
Free/Commissioned
ACF Equity Research
Actio Advisors
Align Research
Atrium Research
BlytheRay
BNP Paribas Exane - Sponsored Research
Brand Communications
BRR Media
Calvine Partners
Capital Access Group
Capital Markets Brokers
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Edison
Equity Development
eResearch
Fidante Partners
Five Minute Pitch TV
focusIR
Fundamental Research Corp
Galliano’s Latin Notes
goetzpartners securities Limited
H2 Radnor
Hardman & Co
Holland Advisors
Hypothesis Research
Inbound Capital
Independent Investment Research
InterAxS Global
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Magnitogorsk Iron and steel works
Mello Events
Mining Network
NuWays
Paul Scott
Peel Hunt
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Resolve Research
SEAL Advisors Ltd
ShareSoc
Shore Capital
Small Cap Consumer Research LLC
StockBox
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
Turner Pope Investments
UK Investor Group
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
High Net Worth Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
Baptista Research
BNP Paribas Exane - Sponsored Research
Canaccord Genuity
Cavendish
Couloir Capital
Dowgate Capital
First Berlin
First Sentinel
GSBR Research
Hannam & Partners
Hybridan
Kemeny Capital
Liberum
Longspur Clean Energy
Louis Capital
Magnitogorsk Iron and steel works
Medley Global Advisors
Northland Capital Partners
QuotedData Professional
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
Tennyson Securities
The Life Sciences Division
Turner Pope Investments
VSA Capital
WHIreland
Whitman Howard
Yellowstone Advisory
Zeus Capital
Institutional Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
BNP Paribas Exane
BRR Media
Calvine Partners
Canaccord Genuity
Capital Access Group
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Dowgate Capital
Edison
Equity Development
eResearch
Fidante Partners
First Berlin
First Sentinel
Five Minute Pitch TV
Fundamental Research Corp
Galliano’s Latin Notes
Goodbody
H2 Radnor
Hannam & Partners
Hardman & Co
Holland Advisors
Hybridan
Inbound Capital
Independent Investment Research
InterAxS Global
Investec Bank
Kemeny Capital
Kepler | Absolute Hedge
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Longspur Clean Energy
Magnitogorsk Iron and steel works
Mello Events
Mining Network
Northland Capital Partners
Numis
NuWays
Panmure Gordon
Peel Hunt
piworld.co.uk
Proactive
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
Small Cap Consumer Research LLC
SP Angel
Stanford Capital Partners
Stifel
StockBox
Tamesis Partners
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
UK Investor Group
Velocity Trade
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
Contact
Sign Up
Sign In
Share: